![David W. Carley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David W. Carley
Chief Tech/Sci/R&D Officer at Pier Pharmaceuticals, Inc.
David W. Carley active positions
Companies | Position | Start | End |
---|---|---|---|
Pier Pharmaceuticals, Inc.
![]() Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Director/Board Member | 2011-06-28 | - |
Chief Tech/Sci/R&D Officer | 2011-06-28 | - | |
University of Illinois | Corporate Officer/Principal | 2011-06-28 | - |
Career history of David W. Carley
Former positions of David W. Carley
Companies | Position | Start | End |
---|---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Director/Board Member | 2012-08-09 | - |
Training of David W. Carley
Massachusetts Institute of Technology | Graduate Degree |
Harvard University | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Director/Board Member | 2 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
Private companies | 1 |
---|---|
Pier Pharmaceuticals, Inc.
![]() Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Health Technology |
- Stock Market
- Insiders
- David W. Carley
- Experience